Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - March 23, 2019

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/17 - Asia Pacific Entrepreneurship Awards 2017 honors Generika president [Business Mirror (Philippines)]
Teodoro L. Ferrer, President of Generika Drugstore, received Enterprise Asia's Asia Pacific Entrepreneurship Award in the Healthcare and Pharmaceutical Industry during the awards ceremony on December 7, held at the Rizal Ballroom of Makati Shangri-La. Enterprise Asia is the leading non-governmental organization for entrepreneurship in the region.
12/31/17 - Autism therapy: Social behavior restored via brain stimulation
By a News Reporter-Staff News Editor at VerticalNews Health& Science Scientists are examining the feasibility of treating autistic children with neuromodulation after a new study showed social impairments can be corrected by brain stimulation. The research from the O'Donnell Brain Institute provides the first evidence that a specific part of the.
12/31/17 - Have you heard about vitamins lately?
Has anyone noticed the increased cost of supplements and manufactured feeds lately? In beef cattle nutrition, it seems a lot of attention is given and information is reported, regarding the importance of nutrients like protein, macro and trace minerals, fats and carbohydrates. Vitamins get attention as well and are about to get a lot more.
12/31/17 - How good are gummy supplements?
Q. I always take my vitamins if they are gummies. I really like the sweetness. I am less apt to take supplements as capsules.
12/31/17 - Insilico to present the recent advances in AI for aging research at the 25th annual A4M Conference
By a News Reporter-Staff News Editor at VerticalNews Health& Science Insilico Medicine, a Baltimore- based company specializing in the application of artificial intelligence for drug discovery, biomarker development and aging research, is pleased to announce the lecture of its founder and CEO, Dr. Alex Zhavoronkov, at 25th Annual World Congress,
12/31/17 - Lawsuit Shows Big Pharma Will Fight Price Transparency
The Pharmaceutical Research and Manufacturers of America, the industry s main lobbying group, filed a lawsuit recently seeking to derail a California law that will require 60 days notice before drugmakers raise prices beyond a certain threshold. Jerry Brown as a defendant, drug companies argue that the state is attempting to dictate national
12/31/17 - Lehner's death, Paladino removal from School Board among 2017's top stories [The Buffalo News, N.Y.]
The stories include the death of Buffalo Police Office Craig Lehner, the removal of Carl Paladino from the Buffalo school board, Ross Cellino's split from the legal duo of Cellino and Barnes, management shakeups at professional football and hockey teams, and the abrupt resignation of local Empire State Development leader Sam Hoyt. This region also
12/31/17 - NAB approves corruption probe against NWA Agency Surgeon, FDA, FATA Secretariat officers
PESHAWAR: The National Accountability Bureau has approved inquiry against Agency Surgeon of North Waziristan, FATA Secretariat and FATA Development Authority officers over corruption and misuse of powers. The Executive Board of the NAB Khyber Pakhtunkhwa met in Peshawar on Thursday with the director general in the chair. Inquiry was also approved..
12/31/17 - Suits seek to recoup opioid costs Tactics differ for city, county
Fort Wayne and Allen County officials this winter are part of an avalanche- of lawsuits. The powerful prescription painkilling drugs ended the lives of about 150 Fort Wayne residents in 2017 alone. "The monetary cost to governmental agencies is in the tens of billions of dollars each year," according to a statement from the Indianapolis law firm o
12/31/16 - Toxic Beauty: Bed, bath and way beyond
Heavy Metal and makeup have more in common than you might know. Lipsticks, mascara, sunblock, and deodorant are just a few of the toxic products that contain levels of heavy metals and other substances that are unregulated by the FDA. Unlike drug companies, cosmetics companies may use almost any ingredients they choose, with few exceptions.
12/30/17 - Acceleron Pharma Assigned Patent for Methods for Treating Ulcers
Acceleron Pharma, Cambridge, Massachusetts, has been assigned a patent developed by Kenneth M. Attie, Boston, Massachusetts, for "methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide." The patent application was filed on June 12, 2015. Written by Subhashree Samal; edited by Sudarshan Harpal.
12/30/17 - Aga Khan University Hospital Becomes First In E. A. to Acquire Ultra-Modern PET CT Scanner [Tehran Times (Iran)]
Aga Khan University Hospital in Nairobi has acquired an ultra-modern Positron Emission Tomography CT scanner and Cyclotron, a first in East and Central Africa. Aga Khan University Hospital continues to be at the front of the fight against non-communicable diseases through evidence-based medicine backed by res-earch, a team-based approach and modern
12/30/17 - Agios Pharmaceuticals Assigned Patent for Therapeutically Active Compositions
Agios Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by six co-inventors for "therapeutically active compositions and their methods of use." The co-inventors are Janeta Popovici-Muller, Windham, New Hampshire, Rene M. Lemieux, Charlestown, Massachusetts, Jeremy Travins, Southborough, Massachusetts, Zhenwei Cai, Skil
12/30/17 - Albireo Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Sudan Tribune]
-Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant to two employees of inducement stock options exercisable for an aggregate of 37,000 shares of Albireos common stock. The stock options are exercisable at a price of $26.12 per share, the closing price of Al
12/30/17 - Alnylam Pharmaceuticals Assigned Patent for Complement Component C5 iRNA Compositions
Alnylam Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by 10 co-inventors for "complement component C5 iRNA compositions and methods of use thereof." The co-inventors are Kevin Fitzgerald, Brookline, Massachusetts, James Butler, Lynnfield, Massachusetts, Brian Bettencourt, Groton, Massachusetts, Anna Borodovsky, Mel
12/30/17 - Aptose`s pan-FLT3/pan-BTK inhibitor, CG806 to treat AML receives US FDA orphan drug status [T-break Tech (Middle East)]
Aptose Biosciences, a clinical-stage biotechnology company, has announced that the US Food and Drug Administration has granted orphan drug designation to CG806, a highly potent pan-FLT3/pan-BTK inhibitor, for the treatment of patients with acute myeloid leukemia. We are pleased that the FDA has recognized the unique potential of CG806 to address AM
12/30/17 - ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 [ (United Arab Emirates)]
-The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased Array Biopharma Inc. securities between December 16, 2015 and March 17, 2017. According to the complaint, throughout the class period Array issued material fal
12/30/17 - Atara Biotherapeutics Announces FDA Clearance to Initiate Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) [Tehran Times
Atara Biotherapeutics, Inc., a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced that it received clearance from the U.S. Food and Drug Administration to initiate two Phase 3 clinical studies with tabelecleucel in patients with rituximab-refractory
12/30/17 - Attention Biotech Investors: Brace For These January PDUFA Events
The biotech sector rebounded in 2017, with the iShares NASDAQ Biotechnology Index rallying more than 21 percent. This follows an underwhelming performance in 2016, when the IBB lost 21.6 percent. Synergy Seeks Approval for Expanded Use Of Its Constipation Drug Company: Synergy Pharmaceuticals Inc Type of Application: Supplemental New Drug Applicati
12/30/17 - Avadel Pharmaceuticals Issues 2018 Corporate Outlook [Tehran Times (Iran)]
-Avadel Pharmaceuticals plc, Avadel or the Company, today announced its 2018 corporate objectives and financial expectations, including the commercial launch of Noctiva and the anticipated filing of a New Drug Application for both FT218, a once-nightly formulation of sodium oxybate using Micropump, and its fourth Unapproved Marketed Drug product, A
12/30/17 - Biosimilar medicines could drive down costs, increase access to care for New Jersey residents Biosimilars could drive down costs, increase access to care in NJ, says Stacie Phan
For New Jersey, where nearly one in three people say their health care costs are unreasonable, a robust biosimilars marketplace could have enormous benefits for residents in need of care while reining in ever-increasing health care spending. While most residents of New Jersey may be unfamiliar with the term "biosimilars," they are commonly used thr
12/30/17 - Boryung Vigencell to enter phase 2 studies on T-cell immunotherapy [Sport360]
Boryung Vigencell, an affiliate of Korean drug maker Boryung Pharmaceutical, said on Dec. 28 that the countrys regulator has approved its Investigational New Drug application to initiate phase 2 clinical trials of its T-cell immunotherapy. The company was able to create tumor-specific cytotoxic T-cells which play a vital role in the immune respon
12/30/17 - Chugai Pharma to inject $220m into Singapore bio drug lab [Arab Times (Kuwait)]
Japan`s Chugai Pharmaceutical looks to invest some 25 billion yen into a Singapore research center for biopharmaceuticals by 2021, seeking to better compete with a host of nimble bioventures. The Singapore lab also will take up research and development to make antibodies more functional, a task now handled by a facility west of Tokyo. Chugai aims t
12/30/17 - Construction begins on Vetter headquarters in Des Plaines [ (United Arab Emirates)]
German pharmaceutical company Vetter Pharma has started construction on its $350 million U.S. headquarters in Des Plaines. The first phase of construction at the 17- acre site at Mount Prospect and Algonquin roads began this month with renovations to the existing five-story office building formerly owned by the Salvation Army. That will clear the w
12/30/17 - CStone`s anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia [Syrian Arab News Agency]
CStone Pharmaceuticals Co., Ltd, today announced that an investigational new drug filing has been submitted to Human Research Ethics Committees of the Ashford Cancer Center in Australia for CS1002, an independently-developed investigational cytotoxic T-lymphocyte-associated protein-4 inhibitor. Frank Jiang, Chief Executive Officer of CStone...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement